相关实验视频
Updated: Jun 11, 2025

13:00
Engineering Antiviral Agents via Surface Plasmon Resonance
Published on: June 14, 2022
2.3K
针对SARS-CoV-2 RBD/hACE2相互作用的潜在阻断的研究
Sara M Villada-Troncoso1, Jenny Andrea Arévalo-Romero1,2, Vanessa Hernández Rivera3
1Institute for the Study in Inborn Errors of Metabolism-IEIM, Faculty of Science, Pontificia Universidad Javeriana, Bogotá 110231, Colombia.
Pharmaceuticals (Basel, Switzerland)
|September 28, 2024
概括
研究人员通过实验验证了三种 (BP2,BP9,BP11) 阻止SARS-CoV-2尖端蛋白与人体细胞结合. 酸BP2表现出最强大的抗病毒活性,显示出新的COVID-19治疗方法的前景.
科学领域:
- 病毒学 病毒学
- 生物技术是生物技术.
- 药物发现 药物发现 药物发现
背景情况:
- 严重急性呼吸道综合征冠状病毒2 (SARS-CoV-2) 导致COVID-19,由于新出现的变种,需要新的治疗方法.
- 病毒通过尖端蛋白的受体结合域 (RBD) 进入细胞,与人体血管素转化酶2 (ACE2) 结合.
- 之前的in silico研究确定了类BP2,BP9和BP11作为RBD-ACE2相互作用的潜在破坏者.
研究的目的:
- 实验验证类BP2,BP9和BP11在抑制SARS-CoV-2 RBD-ACE2相互作用中的有效性.
- 评估这些的生产产量和结合能力与各种RBD变体相比.
- 确定针对SARS-CoV-2的治疗开发最有前途的.
主要方法:
- 在酵母 Komagataella phaffii 中,复合生成的质BP2,BP9和BP11.
- 在实验室中评估活性,使用具有多个RBD变异的结合试验.
- 评估RBD-ACE2相互作用的抑制,并确定IC50值.
主要成果:
- 酸BP2,BP9和BP11已成功生产,产量分别为14.34,4.01,1.35毫克/升.
- 这三种都表现出来自SARS-CoV-2变异的RBD的相互作用,BP2显示出优越的识别能力.
- 这些抑制了RBD/hACE2相互作用,IC50值在1.03至5.35nm之间,BP2是最有效的.
结论:
- 酸BP2作为开发针对SARS-CoV-2的新型干预措施的治疗候选者,显示出显著的前景.
- 这些发现支持BP2和相关在向利用haCE2进入细胞的冠状病毒方面的潜力.
- 实验验证证证实了in silico预测,为进一步的药物开发工作铺平了道路.
更多相关视频
相关概念视频
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
490
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
490
Protein-protein Interfaces
12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K

